PRLR and cancer: In T47D-Y cells lacking PRs and exhibiting a more aggressive undifferentiated phenotype, the suppression of FASN signaling was accompanied by a partial recovery of prolactin secretory activation, up-regulation of PRLR expression, and down-regulation of EMT/cancer stem cell/pro-inflammatory markers such as IL-6.